Literature DB >> 897341

Quantitation of digoxigenin in serum following oral administration of digoxin in humans.

J C Loo, I J McGilveray, N Jordan.   

Abstract

Separation of the acid breakdown products from digoxin in serum was accomplished by high performance liquid chromatography (HPLC). The major, less cardioactive, product digoxigenin was quantitated by several different commercial antisera from digoxin radioimmunoassay (RIA) kits. When two normal subjects were given digoxigenin (0.5 mg) orally appreciable concentrations were detected by digoxin RIA kit. Administration of a digoxin (0.5 mg) solution to the same overnight-fasted recumbent volunteers resulted in digoxigenin detection (HPLC-RIA) in serum only in one subject.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 897341

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  7 in total

1.  Digoxin dosage in patients with gastric hyperacidity.

Authors:  I J McGilveray; J C Loo; N Jordan; S Nattel; J Ruedy
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

Review 2.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

4.  [Distribution of digoxin, digitoxin and their cardioactive metabolites in human heart and kidney tissue. A postmortem study].

Authors:  J Plum; T Daldrup
Journal:  Z Rechtsmed       Date:  1985

5.  Investigation of cardiac glycoside levels in human post mortem blood and tissues determined by a special radioimmunoassay procedure.

Authors:  R Aderjan; H Buhr; G Schmidt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

6.  The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.

Authors:  A F Cohen; R Kroon; H C Schoemaker; D D Breimer; A Van Vliet-Verbeek; H C Brandenburg
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

7.  Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.

Authors:  J O Magnusson; B Bergdahl; C Bogentoft; S Gustafsson; U E Jonsson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.